Paul R. Thompson

Overview

Best Publications

• NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis

  Ritika Khandpur;Carmelo Carmona-Rivera;Anuradha Vivekanandan-Giri;Alison Gizinski

  1451
  Citations

• Diverse stimuli engage different neutrophil extracellular trap pathways

  Elaine F Kenny;Alf Herzig;Renate Krüger;Aaron Muth

  800
  Citations

• Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

  Huw D Lewis;John Liddle;Jim E Coote;Stephen J Atkinson

  768
  Citations

• Succination inactivates gasdermin D and blocks pyroptosis

  Fiachra Humphries;Liraz Shmuel-Galia;Natalia Ketelut-Carneiro;Sheng Li

  615
  Citations

• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

  J Han;P Thompson;B Beutler

  610
  Citations

• The structural basis of protein acetylation by the p300/CBP transcriptional coactivator

  Xin Liu;Ling Wang;Kehao Zhao;Kehao Zhao;Paul R. Thompson;Paul R. Thompson

  529
  Citations

• Regulation of the p300 HAT domain via a novel activation loop

  Paul R Thompson;Paul R Thompson;Dongxia Wang;Ling Wang;Marcella Fulco

  502
  Citations

• Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis

  Jason S. Knight;Wei Luo;Alexander A. O’Dell;Srilakshmi Yalavarthi

  473
  Citations

• Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice

  Jason S Knight;Venkataraman Subramanian;Alexander A O'Dell;Srilakshmi Yalavarthi

  439
  Citations

• Activation of PAD4 in NET formation

  Amanda S. Rohrbach;Daniel J. Slade;Paul R. Thompson;Kerri A. Mowen

  402
  Citations

• Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus

  Jason S. Knight;Wenpu Zhao;Wei Luo;Venkataraman Subramanian

  392
  Citations

• Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization

  Yuan Luo;Kyouhei Arita;Monica Bhatia;Bryan Knuckley

  346
  Citations

• Chemical biology of protein arginine modifications in epigenetic regulation.

  Jakob Fuhrmann;Kathleen W. Clancy;Paul R. Thompson

  333
  Citations

• N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis

  Van C. Willis;Alison M. Gizinski;Nirmal K. Banda;Corey P. Causey

  325
  Citations

• Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

  Erin E. Witalison;Paul R. Thompson;Lorne J. Hofseth

  315
  Citations

• A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

  Unknown

  313
  Citations

• Structure of an Enzyme Required for Aminoglycoside Antibiotic Resistance Reveals Homology to Eukaryotic Protein Kinases

  Wai-Ching Hon;Geoffrey A. McKay;Paul R. Thompson;Robert M. Sweet

  304
  Citations

• Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis.

  Carmelo Carmona-Rivera;Philip M. Carlucci;Erica Moore;Nithya Lingampalli;Nithya Lingampalli

  301
  Citations

• Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4

  Pingxin Li;Hongjie Yao;Zhiqiang Zhang;Ming Li

  283
  Citations

• Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential

  Justin E Jones;Corey P Causey;Bryan Knuckley;Jessica L Slack-Noyes

  260
  Citations

• The protein arginine deiminases: Structure, function, inhibition, and disease.

  Kevin L. Bicker;Paul R. Thompson

  241
  Citations